Bone Biologics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Bone Biologics Stock Summary

Bone Biologics competes with Bluejay Diagnostics, Nuwellis, Heart Test, Tivic Health, and Vivos Therapeutics. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company was founded in 2004 and is headquartered in Burlington, Massachusetts. Bone Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.

Bone Biologics Key Financial Ratios

Bone Biologics Key Balance Sheet Accounts

Bone Biologics Key Income Statement Accounts

Bone Biologics Key Cash Accounts

Bone Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bone Biologics's current stock value. Our valuation model uses many indicators to compare Bone Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bone Biologics competition to find correlations between indicators driving Bone Biologics's intrinsic value. More Info.Bone Biologics Corp is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Bone Biologics' Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bone Biologics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Bone Biologics Corp Systematic Risk

Today, most investors in Bone Biologics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bone Biologics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Bone Biologics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Bone Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bone Biologics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bone Biologics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Bone Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bone Biologics's daily price indicators and compare them against related drivers.

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.